Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/87123
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The efficacy and effectiveness of continuous glucose monitoring during pregnancy: a systematic review |
Author: | Voormolen, D. DeVries, J. Evers, I. Mol, B. Franx, A. |
Citation: | Obstetrical and Gynecological Survey, 2013; 68(11):753-763 |
Publisher: | Lippincott, Williams & Wilkins |
Issue Date: | 2013 |
ISSN: | 0029-7828 1533-9866 |
Statement of Responsibility: | Daphne N. Voormolen, J. Hans DeVries, Inge M. Evers, Ben W. J. Mol, and Arie Franx |
Abstract: | Objective: Diabetic pregnancies carry a high risk for both mother and child, especially when glycemic control is poor. A novel technique that aims to improve glycemic control is the continuous glucose monitor (CGM). This tool is already in use to improve pregnancy outcome. This review presents the available evidence on the efficacy of CGM use in pregnancy and the effectiveness on pregnancy outcome. Methods: A systematic search was conducted using PubMed, EMBASE, and the Cochrane Libraries for articles on CGM in pregnancy. We evaluated the selected articles with particular attention for clinical and cost-effectiveness of CGM to improve pregnancy outcome. Results: We retrieved 5032 articles, 11 of which remained as relevant after selection according to predefined criteria. Most studies were limited to the evaluation of the role of CGM on clinical decision making. Only 2 studies were randomized controlled trials (RCTs) evaluating the effect on pregnancy outcome. One small RCT on retrospective CGM showed a significant reduction in third-trimester HbA1c and a significant reduction in neonatal macrosomia. A second RCT on real-time CGM did not show any effect on either glycemic control or on pregnancy outcome. Conclusions: Current evidence on the efficacy of CGM on improving glycemic control during pregnancy as well as on the effectiveness on pregnancy outcome is limited to 2 RCTs with contradicting results. Evidence on the cost-effectiveness is lacking. Further proper RCTs on the effectiveness and cost-effectiveness of CGM in pregnancy are required before wide implementation in practice. |
Keywords: | Humans Pregnancy in Diabetics Diabetes Mellitus, Type 1 Blood Glucose Monitoring, Ambulatory Pregnancy Outcome Pregnancy Cost-Benefit Analysis Female |
Rights: | Copyright © 2013 by Lippincott Williams & Wilkins |
DOI: | 10.1097/OGX.0000000000000002 |
Published version: | http://dx.doi.org/10.1097/ogx.0000000000000002 |
Appears in Collections: | Aurora harvest 2 Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.